ResMed reported $35.4B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 3.36B 450.92M Dec/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 2.95B 90M Nov/2026
Baxter International USD 12.41B 1.4B Sep/2026
Cochlear AUD 17.05B 2.6B Dec/2025
Cooper Companies USD 14.1B 1.83B Jun/2026
CSL USD 55.89B 20.42B Dec/2025
Dexcom USD 32.56B 6.57B Sep/2026
Edwards Lifesciences USD 58.61B 8.86B Nov/2026
Fisher Paykel Healthcare NZD 21.96B 201.12M Jun/2026
Globus Medical USD 11.02B 969M Nov/2026
Haemonetics USD 6.3B 1.51B Nov/2026
Idexx Laboratories USD 56.98B 15.84B Nov/2026
Insulet USD 11.54B 2.49B Nov/2026
Integra LifeSciences USD 1.27B 131M Sep/2026
Intuitive Surgical USD 143.65B 2.81B Sep/2026
Medtronic USD 109.3B 2.33B Jun/2026
Philips EUR 24.82B 3.69B Nov/2026
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 28.27B 4.43B Jun/2026
Sigma Healthcare AUD 2.68B 2.01B Sep/2026
Steris USD 24.5B 4.02B Nov/2026
Teleflex USD 7.16B 1.86B Nov/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026